Higher Insulin Resistance and Adiposity in Postmenopausal Women With Breast Cancer Treated With Aromatase Inhibitors

CONTEXT: Aromatase deficiency causes obesity and insulin resistance in aromatase knockout mice and humans with rare mutations of the aromatase gene (CYP19). Aromatase inhibitors are a commonly prescribed therapy for postmenopausal breast cancer. OBJECTIVE: We hypothesized that aromatase inhibitors i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibb, Fraser W, Dixon, J Michael, Clarke, Catriona, Homer, Natalie Z, Faqehi, Abdullah M M, Andrew, Ruth, Walker, Brian R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642666/
https://www.ncbi.nlm.nih.gov/pubmed/30920624
http://dx.doi.org/10.1210/jc.2018-02339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642666/
https://www.ncbi.nlm.nih.gov/pubmed/30920624
http://dx.doi.org/10.1210/jc.2018-02339

Ejemplares similares